Showing results (731-740 of 5,929) with videos related to
Sort By:
Pageof 593
The Prostate|July 12, 2002
Insulin-like growth factors and risk of benign prostatic hyperplasiaAnand P Chokkalingam, Yu-Tang Gao, Jie Deng, et al.The Prostate|July 12, 2002
Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivityStephanie W F Siu, Kai W Lau, Po C Tam, et al.The Prostate|September 21, 2002
Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancerJames Gulley, Alice P Chen, William Dahut, et al.The Prostate|September 21, 2002
Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinomaThomas Fixemer, Klaus Remberger, Helmut BonkhoffThe Prostate|September 21, 2002
Expression of focal adhesion kinase in normal and pathologic human prostate tissuesJoshua D Rovin, Henry F Frierson, Wayne Ledinh, et al.The Prostate|September 21, 2002
Differential expression of 17beta-hydroxysteroid dehydrogenase isozyme genes in prostate cancer and noncancer tissuesEitetsu Koh, Toru Noda, Jiro Kanaya, et al.The Prostate|March 18, 2003
Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell lineJason J Christiansen, Sigrid A Rajasekaran, Peggy Moy, et al.The Prostate|May 15, 2003
A novel method of generating prostate cancer metastases from orthotopic implantsEva Corey, Janna E Quinn, Robert L VessellaThe Prostate|May 15, 2003
PRAC2: a new gene expressed in human prostate and prostate cancerPär Olsson, Akira Motegi, Tapan K Bera, et al.The Prostate|May 15, 2003
ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002Niels Tørring, Frederik Dagnaes-Hansen, Boe Sandahl Sørensen, et al.Pageof 593